featured
Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma
N. Engl. J. Med 2018 Nov 08;379(19)1811-1822, MA Dimopoulos, D Dytfeld, S Grosicki, P Moreau, N Takezako, M Hori, X Leleu, R LeBlanc, K Suzuki, MS Raab, PG Richardson, M Popa McKiver, YM Jou, SG Shelat, M Robbins, B Rafferty, J San-MiguelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.